Biotechs Survive 2018 Bottom And Catch A Rally
Biotechs Survive 2018 Bottom But Enthusiasm Is Sketchy Mid-Caps Should Move with M&A and News-Big Movers Today Celgene Beats on Earnings and Strong Revlimid and Pomalyst Sales The overall market rallied today with good strength in Nasdaq up 1.71 % and the QQQ up even better up 1.9% helped by AAPL up 3.97% on a huge…